产品分类 PRODCT
文章详情

生物药**结构相似性分析案例一

日期:2024-05-11 22:09
浏览次数:267
摘要:**结构HOS相似性分析方法示例
Introduction

Results: HOS analysis possible in a highly absorbing, ‘CD-active’ formulation buffer Methods


During biotherapeutic development a wide range of biophysical
characterization techniques are required to support informed decision
making and contribute to the totality of evidence in regulatory sub
missions. Regulatory authorities are increasing their demand for
‘state-of-the-art’ techniques that can provide statistically-validatable
data. To date, obtaining such results for higher order structure (HOS)
comparisons has presented challenges in terms of data acquisition
and suitability of statistical methods.
Here we present a novel, integrated approach to HOS analysis to
generate an objective, quantifiable comparison of a commercially
available biotherapeutic (Fab fragment) with a biosimilar currently
under development.

沪公网安备 31010602002613号